Kebuzone
From Wikipedia, the free encyclopedia
 |
|
|
Kebuzone
|
|
| Systematic (IUPAC) name | |
| 4-(3-oxobutyl)-1,2-di(phenyl)pyrazolidine-3,5-dione | |
| Identifiers | |
| CAS number | |
| ATC code | M01 |
| PubChem | |
| Chemical data | |
| Formula | C19H18N2O3 |
| Mol. mass | 322.35782 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Kebuzone (or ketophenylbutazone) is a non-steroidal anti-inflammatory drug.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||||||||||||||||||||||||||||||||
